Loss of gastrointestinal neuronal nitric oxide synthase (nNOS) activity is one of the major putative mechanisms for the development of diabetic complications involving the gut, including gastroparesis and
This approval now allows Ethex Corporation, KV’s wholly-owned generic/non-branded subsidiary, to offer a full line of all strengths of this product. Ethex Corporation has commenced the launch of
Furthermore, Epix has completed enrollment of its Phase IIa clinical trial of PRX-03140 in Alzheimer’s disease and reaffirmed that it is on track to announce the findings of
The Phase III program consisted of two studies that compared the safety and efficacy of difluprednate 0.05% to placebo, dosed two (BID) or four (QID) times daily beginning
The agreement grants to MedImmune non-exclusive license rights to develop, manufacture and market antibodies based on Potelligent technology for an undisclosed number of targets. In return, BioWa receives
The partnership matches Novogen’s focus on the identification, preparation, analysis and production of compounds with a leading global beauty company. According to Novogen, a number of its compounds
Additionally, Claritin tablets and Claritin Reditab tablets have been approved for these uses in patients over the age of seven. In Japan, Schering-Plough co-markets the Claritin line of
The orally administered drug, MKC-1, increased survival of tumor-bearing animals in this model. An examination of tumors following five days of oral treatment revealed inhibition of the Akt-mTOR
In an established animal model, anaphylactoid clinical reactions were observed following Taxotere administration, including decreased respiration, swelling and tremors. Furthermore, decreases in blood pressure and increases in histamine
The lead investors in the transaction are Perceptive Life Sciences Fund, Quogue Capital, SCO Capital Partners and Versant Capital. Ron Bentsur, CEO of XTL, said: “We are very
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.